drugset / Trial / NCT06671821
Long-term Efficacy and Safety of HRS-7535 Tablets in Obese Subjects
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The Objective of this trial is to evaluate the long-term safety, tolerability, weight loss efficacy and metabolic benefits of HRS-7535 tablets inobesity.
Timeline
- Start
- 2024-11-20
- Primary completion
- 2025-08-15
- Completion
- 2025-09-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-7535 | Small molecule | — | Oral |
Indications
No indication recorded.